A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
Alzheimers Res Ther. 2017 Dec 8;9(1):95. doi: 10.1186/s13195-017-0318-y.
Alzheimers Res Ther. 2017.
PMID: 29221491
Free PMC article.
Clinical Trial.